← Back to Intel
Insider ActivityDFTX
Barrow Robert, Chief Executive Officer at Definium Therapeutics, Inc., sold $451K of DFTX
Updated Jun 14, 2026
Barrow Robert
Chief Executive Officer
Definium Therapeutics, Inc. ·
$DFTX
Transaction Details
| Insider | Barrow Robert |
|---|---|
| Title | Chief Executive Officer |
| Company | Definium Therapeutics, Inc. |
| Ticker | DFTX |
| Transaction Type | Sale |
| Transaction Date | 2026-03-25 |
| Shares Traded | 24,431 |
| Price Per Share | $18.47 |
| Total Value | $451K |
| Filed Date | 2026-03-26 |
| Accession Number | 0001193125-26-126825 |
Ownership Context
| Shares Owned After Transaction | 752,454 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001193125-26-126825
Other Insider Trades — DFTX
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Karlin Daniel | Chief Medical Officer | sold | $148K | 2026-03-25 |
| Sullivan Mark | Chief Legal Officer | sold | $198K | 2026-03-25 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for DFTX — Definium Therapeutics, Inc. →
Whisper Score — DFTX
62.88
Frenzy
Current Whisper Score
Track DFTX insider activity in real time on The Wire →
Get alerts when Barrow Robert files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 14, 2026 at 07:22 UTC